Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 310,543 |
|
|||||
| News | - | ||||||
| Day High | 12.47 | Low High |
|||||
| Day Low | 12.1123 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Dynavax Technologies Corp | DVAX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.09 | -0.73% | 12.23 | 11:12:55 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.17 | 12.1123 | 12.47 | 12.32 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,811 | 310,543 | US$ 12.24 | US$ 3,802,098 | - | 10.48 - 15.15 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:12:55 | 100 | US$ 12.23 | USD |
Dynavax Technologies Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.59B | 130.61M | - | 232.28M | -6.39M | -0.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Dynavax Technologies News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DVAX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.30 | 12.86 | 11.285 | 11.84 | 2,851,059 | 0.93 | 8.23% |
| 1 Month | 11.62 | 12.86 | 10.48 | 11.46 | 2,436,814 | 0.61 | 5.25% |
| 3 Months | 12.94 | 12.945 | 10.48 | 11.73 | 2,180,402 | -0.71 | -5.49% |
| 6 Months | 13.77 | 15.01 | 10.48 | 12.57 | 2,018,577 | -1.54 | -11.18% |
| 1 Year | 11.53 | 15.15 | 10.48 | 13.13 | 1,853,514 | 0.70 | 6.07% |
| 3 Years | 8.62 | 21.39 | 7.26 | 13.12 | 2,161,825 | 3.61 | 41.88% |
| 5 Years | 4.70 | 21.39 | 1.80 | 9.89 | 2,644,021 | 7.53 | 160.21% |
Dynavax Technologies Description
| Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product. |
